Skip to main content
Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
2.780
+0.050 (1.83%)
At close: Feb 27, 2026, 4:00 PM EST
2.760
-0.020 (-0.72%)
After-hours: Feb 27, 2026, 7:55 PM EST

Allogene Therapeutics Revenue

In the year 2024, Allogene Therapeutics had annual revenue of $22.00K, down -76.84%.

Revenue (ttm)
$22.00K
Revenue Growth
-76.84%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
229
Market Cap
624.75M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202422.00K-73.00K-76.84%
Dec 31, 202395.00K-61.00K-39.10%
Dec 31, 2022156.00K-113.93M-99.86%
Dec 31, 2021114.09M--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Rigel Pharmaceuticals 282.08M
Lexicon Pharmaceuticals 70.86M
MeiraGTx Holdings 27.42M
Ocugen 5.37M
YD Bio 510.36K
Revenue Rankings

ALLO News

More News